Proqr Therapeutics Ii competitive analysis

Loading summary...

Explore Proqr Therapeutics Ii's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 7, 2020Chemically Modified Single-Stranded Rna-Editing Oligonucleotides1
May 27, 2020Targeted Rna Editing2

Latest publications and patents of Proqr Therapeutics Ii New

Explore the latest publications and patents granted to Proqr Therapeutics Ii, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Proqr Therapeutics Ii

Oct 7, 2020Chemically Modified Single-Stranded Rna-Editing OligonucleotidesGranted And Under Opposition
May 27, 2020Targeted Rna EditingGranted And Under Opposition

Latest PTAB cases involving Proqr Therapeutics Ii

Discover the latest PTAB cases involving Proqr Therapeutics Ii, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Proqr Therapeutics Ii with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PROQR THERAPEUTICS II - 3 - -
MARGARET DIXON59 - - -
STRAWMAN336 - - -